NCT04664660

Brief Summary

The purpose of this study is to assess if endometriosis can be considered a risk factor for adverse obstetric and delivery outcomes

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

11 months

First QC Date

December 7, 2020

Last Update Submit

December 11, 2020

Conditions

Keywords

EndometriosisObstetric outcomeDelivery outcomeNeonatal outcome

Outcome Measures

Primary Outcomes (8)

  • Preterm delivery

    Incidence of delivery before 37 weeks of pregnancy

    Time of delivery

  • Gestational diabetes

    fasting blood glucose \>17 mmol/L

    after 18 weeks' pregnancy

  • Gestational hypertension

    blood pressure persistently \> 140/90 mm Hg

    after 20 weeks' gestation

  • Assisted reproduction technologies

    Patients who referred to assisted reproduction technologies

    before pregnancy

  • Cesarean Section

    Robson Classifications

    Time of delivery

  • Postpartum hemorrhage

    Greater than 500 mL estimated blood loss in a vaginal delivery or greater than 1000 mL estimated blood loss at the time of cesarean delivery

    Time of delivery

  • Birth-weight

    small for gestational age (birth weight below the 10th percentile) or large for gestational age (birth weight over the 90th percentile)

    Time of delivery

  • Apgar scores

    Apgar scores

    Time of delivery

Study Arms (2)

Patients with previous histologic diagnosis of endometriosis

Other: Retrospective analysis of obstetrics outcomes

Patient without endometriosis

Other: Retrospective analysis of obstetrics outcomes

Interventions

Retrospective analysis of clinical records including general medical and gynecological history, pregnancy course, delivery mode and newborn conditions.

Patient without endometriosisPatients with previous histologic diagnosis of endometriosis

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women who delivered at Azienda Ospedaliero Universitaria Policlinico di Modena from 2000 to 2020. Women with a histological diagnosis of endometriosis before pregnancy matched by age with healthy controls.

You may qualify if:

  • Pregnant women who delivered at Azienda Ospedaliero Universitaria Policlinico di Modena from 2000 to 2020
  • Histologic diagnosis of endometriosis before pregnancy for case group
  • Age matched healthy patients for control group

You may not qualify if:

  • Clinical records not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carlo Alboni

Modena, 41125, Italy

RECRUITING

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Carlo Alboni MD, PhD Head of Minimally Invasive and Robotic Gynecologic Surgery Unit University Hospital of Modena - Italy

Study Record Dates

First Submitted

December 7, 2020

First Posted

December 11, 2020

Study Start

March 10, 2020

Primary Completion

February 1, 2021

Study Completion

March 1, 2021

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

I prefer not to share individual participant data

Locations